Stocks › EMBC
Embecta Corp.
EMBC·Nasdaq·
United States·USD
United States·USD$5.95
+0.07 (+1.19%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
EMBC
Embecta Corp. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EMBCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EMBC by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Tom ColeHouse · R · OK |
EMBCEmbecta Corp. · Stock |
Exchange $1,001 - $15,000 |
Apr 26, 2022 | Apr 1, 2022 | Filing ↗ |
Whale Activity
Position changes in EMBC reported for 2026-06-30 by 10 tracked institutional filers
- Increased2
- New1
- Held0
- Decreased4
- Closed2
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 4.6M | $15.0M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $8.3M | decreased |
| BRIGADE CAPITAL MANAGEMENT, LP | 1.5M | $4.9M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $3.6M | decreased |
| MILLENNIUM MANAGEMENT LLC | 946.0K | $3.1M | decreased |
| D. E. Shaw & Co., Inc. | 650.1K | $2.1M | increased |
| CITADEL ADVISORS LLC | 446.1K | $1.5M | increased |
| Point72 Asset Management, L.P. | 20.2K | $66K | new |
| Two Sigma Investments, LP | 0 | $0 | closed |
| Renaissance Technologies | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EMBC insiders, by quarter · Form 4
Recent Insider Transactions
135 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Morris Milton MayoDirector · Director | Sale | −6,293 | $5.88 | $37K | Sep 4, 2026 | Form 4 ↗ |
| Kurdikar DevdattPresident and CEO · Director | Purchase | +30.0K | $4.70 | $141K | Aug 12, 2026 | Form 4 ↗ |
| Elguicze JacobSVP and CFO | Purchase | +20.0K | $4.67 | $93K | Aug 12, 2026 | Form 4 ↗ |
| Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLO | Purchase | +20.0K | $4.99 | $100K | Aug 12, 2026 | Form 4 ↗ |
| HOMBACH ROBERT J.Director · Director | Purchase | +45.0K | $4.97 | $224K | Aug 12, 2026 | Form 4 ↗ |
| Roth Anthony M.VP, Chief Accounting Officer | Grant / award | +30.0K | $0.00 | $0 | Jun 1, 2026 | Form 4 ↗ |
| Anderson Carrie LDirector | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| HOMBACH ROBERT J.Director | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| Morris Milton MayoDirector | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| Prange KarenDirector | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| Pomeroy ClaireDirector | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| Reidy Christopher RDirector | Grant / award | +22.8K | $0.00 | $0 | Feb 11, 2026 | Form 4 ↗ |
| Roth Anthony M.Chief Accounting Officer | Tax withholding | −1,881 | $12.57 | $24K | Nov 26, 2025 | Form 4 ↗ |
| Roth Anthony M.Chief Accounting Officer | Grant / award | +32.8K | $0.00 | $0 | Nov 26, 2025 | Form 4 ↗ |
| Casner JeanChief Human Resources Officer | Tax withholding | −3,325 | $12.57 | $42K | Nov 26, 2025 | Form 4 ↗ |
| Casner JeanChief Human Resources Officer | Grant / award | +38.8K | $0.00 | $0 | Nov 26, 2025 | Form 4 ↗ |
| Mann Jeffrey ZSVP, GC, Head Corp. Dev., Secy | Tax withholding | −19.6K | $12.57 | $246K | Nov 26, 2025 | Form 4 ↗ |
| Mann Jeffrey ZSVP, GC, Head Corp. Dev., Secy | Grant / award | +24.5K | $0.00 | $0 | Nov 26, 2025 | Form 4 ↗ |
| Mann Jeffrey ZSVP, GC, Head Corp. Dev., Secy | Grant / award | +79.6K | $0.00 | $0 | Nov 26, 2025 | Form 4 ↗ |
| Kurdikar DevdattPresident and CEO · Director | Tax withholding | −128.6K | $12.57 | $1.6M | Nov 26, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EMBC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iSHARES TRUST | 3.6M | $32.1M | 0.03% | Mar 31, 2026 |
| Small Cap Value Fund AMERICAN CENTURY CAPITAL PORTFOLIOS INC | 2.0M | $17.9M | 0.56% | Mar 31, 2026 |
| AMG Yacktman Fund AMG Funds | 3.5M | $11.4M | 0.16% | Jun 30, 2026 |
| AMG River Road Small Cap Value Fund AMG Funds IV | 820.6K | $7.5M | 0.69% | Apr 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.8M | $6.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.6M | $5.3M | 0.01% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF iSHARES TRUST | 579.1K | $5.1M | 0.07% | Mar 31, 2026 |
| Columbia Small Cap Value Discovery Fund COLUMBIA FUNDS SERIES TRUST I | 1.4M | $5.0M | 0.20% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF SPDR SERIES TRUST | 532.6K | $4.7M | 0.03% | Mar 31, 2026 |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF SPDR SERIES TRUST | 320.1K | $2.8M | 0.07% | Mar 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list EMBC's shares (CUSIP 29082K105), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 4.6M shares7.7%
Jul 8, 2026 · ↗ - River Road Asset Management, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 27, 2026 · ↗ - AMG YACKTMAN FUNDSCHEDULE 13G · passive (13G) · 3.0M shares5.1%
May 5, 2026 · ↗ - YACKTMAN ASSET MANAGEMENT LPSCHEDULE 13G · passive (13G) · 3.7M shares6.2%
May 5, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Embecta Corp. as client
No lobbying filings found naming Embecta Corp. as the client.
Government Contracts
Federal awards to Embecta Corp. · USAspending
No federal contract awards found for Embecta Corp..
U.S. Patents
Recent USPTO applications naming Embecta Corp.
No USPTO patent applications found for Embecta Corp..
Annual Financials
From EMBC's 10-K filings · XBRL
No annual XBRL figures on record for EMBC. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in EMBC's price history.
Material Events (8-K)
Corporate events filed with the SEC
About Embecta Corp.
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersPARSIPPANY, NJ
IncorporatedDE
SEC CIK0001872789 ↗
Former namesBerra Newco, Inc.